ALSCX | NRGEX | ALSCX / NRGEX | |
Total Expense Ratio | 2.04 | 0.03 | 6,800% |
Annual Report Gross Expense Ratio | 2.04 | 0.69 | 296% |
Fund Existence | 39 years | 4 years | - |
Gain YTD | 2.979 | -1.068 | -279% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 198M | 9.06B | 2% |
Annual Yield % from dividends | 0.00 | 0.53 | - |
Returns for 1 year | 6.45 | -2.86 | -225% |
Returns for 3 years | 22.22 | 10.02 | 222% |
Returns for 5 years | -15.68 | N/A | - |
Returns for 10 years | 6.45 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
STRV | 42.77 | 0.07 | +0.16% |
Strive 500 ETF | |||
FMED | 24.42 | 0.03 | +0.14% |
Fidelity Disruptive Medicine ETF | |||
ADME | 50.64 | 0.03 | +0.06% |
Aptus Drawdown Managed Equity ETF | |||
PYPG | 15.66 | -0.11 | -0.73% |
Leverage Shares 2X Long PYPL Daily ETF | |||
CRSH | 3.20 | -0.07 | -2.14% |
YieldMax Short TSLA Option Income Strategy ETF |